CN108295242B - 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 - Google Patents
用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 Download PDFInfo
- Publication number
- CN108295242B CN108295242B CN201610490387.2A CN201610490387A CN108295242B CN 108295242 B CN108295242 B CN 108295242B CN 201610490387 A CN201610490387 A CN 201610490387A CN 108295242 B CN108295242 B CN 108295242B
- Authority
- CN
- China
- Prior art keywords
- extracellular domain
- domain protein
- psoriasis
- protein
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610490387.2A CN108295242B (zh) | 2016-06-28 | 2016-06-28 | 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610490387.2A CN108295242B (zh) | 2016-06-28 | 2016-06-28 | 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108295242A CN108295242A (zh) | 2018-07-20 |
CN108295242B true CN108295242B (zh) | 2021-06-18 |
Family
ID=62871149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610490387.2A Active CN108295242B (zh) | 2016-06-28 | 2016-06-28 | 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108295242B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109705224A (zh) * | 2019-01-15 | 2019-05-03 | 深圳先进技术研究院 | 融合蛋白抗体、增强型疫苗及其制备方法与应用 |
CN111514278B (zh) * | 2020-05-19 | 2022-07-01 | 江苏普瑞康生物医药科技有限公司 | Cd317蛋白在预防和治疗病毒感染中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001077362A1 (fr) * | 2000-04-06 | 2001-10-18 | Chugai Seiyaku Kabushiki Kaisha | Dosage immunologique d'anticorps anti hm1 . 24 |
CN107250360B (zh) * | 2015-10-16 | 2021-03-12 | 深圳先进技术研究院 | c-Rel特异性siRNA及其用于防治自身免疫性银屑病的应用 |
-
2016
- 2016-06-28 CN CN201610490387.2A patent/CN108295242B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108295242A (zh) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6484634B2 (ja) | Il−15ヘテロ二量体タンパク質及びその用途 | |
KR102653758B1 (ko) | 인터류킨-2/인터류킨-2 수용체 알파 융합 단백질 및 사용 방법 | |
US8071716B2 (en) | Thymus-specific protein | |
JP6938565B2 (ja) | Uti融合タンパク質 | |
KR20150121715A (ko) | Csf1 치료제 | |
JP2022518262A (ja) | ナチュラルキラー細胞を刺激するための組成物及び方法 | |
JP2004203890A (ja) | マクロファージ炎症蛋白変種 | |
CN108295242B (zh) | 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 | |
JP3908165B2 (ja) | 多発性硬化症の治療におけるケモカイン変異体 | |
JP5819439B2 (ja) | 修飾されたヒト腫瘍壊死因子受容体−1ポリペプチドまたはその断片及びその製造方法 | |
US11117976B2 (en) | Compositions and methods for regulating erythropoiesis | |
KR20220032610A (ko) | Cmv 감염과 관련된 질병 치료를 위한 융합 독소 단백질 | |
CN113501862B (zh) | 一种多肽及其在制备免疫调节药物中的应用 | |
CA3180108A1 (en) | Engineered interleukin-22 polypeptides and uses thereof | |
CN115515985A (zh) | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 | |
JP2013507913A (ja) | 修飾されたヒト腫瘍壊死因子受容体−1ポリペプチドまたはその断片及びその製造方法 | |
AU2003223832B2 (en) | Chimeric antagonist anth1 | |
CN114380919B (zh) | 经修饰的il-2分子及其用途 | |
WO2022143938A1 (zh) | 一种激活nk细胞的肿瘤免疫治疗方法 | |
KR102231974B1 (ko) | 사람의 프로그램된 세포사멸 단백질(pd-1)에 선택적으로 결합하는 신규한 폴리펩티드 및 이의 용도 | |
Tao et al. | Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta | |
WO2004091650A1 (fr) | Utilisation de la troponine i cardiaque pour preparer des medicaments antitumoraux | |
CN111732631A (zh) | 一种多肽及其在制备治疗和预防肿瘤的药物中的应用 | |
CA3225321A1 (en) | Ptprs in autoimmunity | |
CN117186239A (zh) | 融合蛋白及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181016 Address after: 518055 Nanshan District, Xili, Shenzhen, Guangdong, 1068 A-301, Xue Yuan Avenue, Shenzhen University town. Applicant after: Shenzhen shen-tech advanced Cci Capital Ltd Address before: 518055 No. 1068, Xue Yuan Avenue, Xili University Town, Nanshan District, Shenzhen, Guangdong Applicant before: Shenzhen Advanced Technology Research Inst. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181107 Address after: 518055 Guangdong, Shenzhen, Nanshan District, Xili, 6 Building 5, rich industrial city. Applicant after: Shenzhen benta Biological Technology Co. Ltd. Address before: 518055 Nanshan District, Xili, Shenzhen, Guangdong, 1068 A-301, Xue Yuan Avenue, Shenzhen University town. Applicant before: Shenzhen shen-tech advanced Cci Capital Ltd |
|
GR01 | Patent grant | ||
GR01 | Patent grant |